Login
  • Bookmark
  • PDF
  • Share
  • CaseIQ

Sajan Abraham v. State Of Kerala .

Supreme Court Of India
Feb 26, 2004
Important Paras
Please sign up to view Important Paras.
Smart Summary (Beta)

Factual and Procedural Background

The appellant was apprehended on 10 October 1993 near Blue Tronics Junction, Palluruthy, allegedly in possession of twenty-five ampoules (2 ml each) of buprenorphine hydrochloride (Tidigesic) and three syringes. He was charged under Section 21 of the Narcotic Drugs and Psychotropic Substances Act, 1985 (NDPS Act) and tried before the Ist Additional Sessions Court, Ernakulam, which acquitted him on 5 March 1994.

The State’s appeal (Criminal Appeal No. 533 of 1994) was allowed; the High Court set aside the acquittal, convicted the appellant, and imposed a sentence of rigorous imprisonment for ten years plus a fine of ₹1 lakh (one year’s simple imprisonment in default).

The appellant challenged this conviction in the Supreme Court (Criminal Appeal No. 1022 of 1997), but the appeal was dismissed on 7 August 2001. A review petition (Review Petition (Crl.) No. 1236 of 2001) was subsequently allowed, restoring the criminal appeal to be heard afresh in light of Hussain v. State of Kerala, which recognized buprenorphine as a psychotropic substance capable of falling within the “small quantity” exemption. The present opinion decides that restored appeal.

Legal Issues Presented

  1. Whether possession of twenty-five ampoules of buprenorphine hydrochloride (Tidigesic) constitutes an offence under Section 21 of the NDPS Act when read with Rule 66 of the NDPS Rules, 1985.
  2. Whether a separate permit is required under Rule 66 for an individual to lawfully possess a psychotropic substance within the “small quantity” limit for personal medicinal use.

Arguments of the Parties

Appellant's Arguments

  • The seized quantity—twenty-five ampoules—falls well under the “small quantity” limit (100 dosage units / 1 gram) prescribed for personal medicinal use under Rule 66 of the NDPS Rules.
  • The presence of syringes and supporting testimony (from PW 3 and DW 1) indicate personal consumption rather than commercial activity.
  • In light of Hussain v. State of Kerala, possession within the small-quantity threshold is not punishable under Section 21.

State's Arguments

  • Even if the quantity is small, Rule 66 protection is unavailable without an explicit permit authorizing possession.

Table of Precedents Cited

Precedent Rule or Principle Cited For Application by the Court
Hussain v. State of Kerala, (2000) 8 SCC 139 Recognized buprenorphine as a psychotropic substance; held that possession of a “small quantity” (within limits under Rule 66) for personal use is not punishable under Section 21. Followed to grant the appellant benefit of the small-quantity exception; guided the Court to re-examine conviction on review.
Ouseph alias Thankachan v. State of Kerala, Criminal Appeal No. 1256 of 2001 Drew inference of personal consumption where psychotropic substance was found with syringes; acquittal based on Rule 66 protection. Cited as analogous factual precedent supporting inference that possession accompanied by syringes indicates personal medicinal use.

Court's Reasoning and Analysis

Section 21 penalizes possession of manufactured drugs only when it is “in contravention” of the Act or Rules. Rule 66(2) of the NDPS Rules expressly permits an individual to possess up to one hundred dosage units of a psychotropic substance for personal medical use without prior authorization. The Court noted:

  • The seized twenty-five ampoules represent a quantity far below the prescribed limit (100 dosage units / 1 gram), satisfying Rule 66.
  • Evidence from the investigating officer (PW 3), the appellant’s mother (DW 1), and the recovery of three syringes supported the conclusion that the drug was for personal consumption.
  • The State’s contention that a separate permit is obligatory was rejected. The Court reasoned that Rule 66 itself, enacted under Section 9 of the NDPS Act, constitutes the authorization; no additional permit is required when possession conforms to the Rule’s quantitative and purposive limits.
  • Precedents (Hussain and Ouseph) affirm that possession within the small-quantity limit for personal use does not contravene Section 21.

Consequently, possession by the appellant was deemed lawful under Rule 66 and therefore outside the scope of the penal provision in Section 21.

Holding and Implications

Appeal Allowed; Conviction and Sentence Set Aside; Appellant Acquitted.

The appellant’s bail bonds were discharged. The decision reaffirms that possession of a psychotropic substance within the Rule 66 “small quantity” threshold for personal medicinal use is not an offence under Section 21 of the NDPS Act and that no separate permit is necessary. The ruling follows existing precedent without creating new legal doctrine.

Show all summary ...

B.P Singh, J.— The appellant herein was charged of having committed the offence punishable under Section 21 of the Narcotic Drugs and Psychotropic Substances Act, 1985 (hereinafter referred to as “the NDPS Act”) and was put up for trial before the Ist Additional Sessions Court, Ernakulam. The case of the prosecution was that on 10-10-1993 at about 7.45 p.m he was found in possession of twenty-five ampoules of manufactured drug, namely, buprenorphine hydrochloride (Tidigesic) along with three syringes when he was apprehended on the road near Blue Tronics Junction, Palluruthy. The learned Additional Sessions Judge by his judgment and order dated 5-3-1994 acquitted the appellant of the charge levelled against him. On appeal by the State being Criminal Appeal No. 533 of 1994 the acquittal of the appellant was set aside and the appeal preferred by the State was allowed. The appellant was found guilty of the offence punishable under Section 21 of the NDPS Act and was sentenced to undergo rigorous imprisonment for ten years and to pay a fine of rupees one lakh, in default to undergo simple imprisonment for one year.

2. The appellant preferred an appeal before this Court being Criminal Appeal No. 1022 of 1997 but the same was dismissed by this Court by judgment and order dated 7-8-2001. The appellant then filed a review petition being Review Petition (Crl.) No. 1236 of 2001 which was allowed by this Court and the appeal restored to its original number. The appeal has now been placed before us for disposal.

3. While allowing the review petition this Court observed that the appellant should have taken up a plea in the light of the decision of this Court in Hussain v. State of Kerala (2000) 8 SCC 139 in which the same article buprenorphine hydrochloride (Tidigesic) was found to be a psychotropic substance and the quantity which was found in possession of the accused was within the prescribed limit, being a small quantity. Consequently, benefit of the same was granted to the accused in that case and he was acquitted. This Court felt, while allowing the review petition, that the appellant should be permitted to take up that contention in this case in order to prevent a miscarriage of justice. This Court noticed that the total quantity involved is twenty-five ampoules of buprenorphine hydrochloride (Tidigesic) of 2 ml each. Counsel for the State of Kerala submitted that the limit of small quantity as per the notification is 1 gm. Thus the total quantity seized from the appellant would fall within the limit of small quantity used for medicinal purposes. The appellant was permitted to file a petition seeking permission to raise additional grounds in the appeal.

4. An application has been filed by the appellant for permission to urge additional grounds in his appeal. We allow the said application.

5. It was not disputed before us by the learned counsel appearing on behalf of the State that the total quantity seized from the appellant would fall within the limit prescribed under Section 27 of small quantity to be used for medicinal purpose, namely, 1 gm. It is also not contended that the quantity seized from the appellant was in excess of the quantity prescribed under Rule 66.

6. Section 21 of the NDPS Act, as it stood at the relevant time provided as follows:

“21. Punishment for contravention in relation to manufactured drugs and preparations.—Whoever, in contravention of any provision of this Act, or any rule or order made or condition of licence granted thereunder manufactures, possesses, sells, purchases, transports, imports inter-State, exports inter-State or uses any manufactured drug or any preparation containing any manufactured drug shall be punishable with rigorous imprisonment for a term which shall not be less than ten years but which may extend to twenty years and shall also be liable to fine which shall not be less than one lakh rupees but which may extend to two lakh rupees:
Provided that the court may, for reasons to be recorded in the judgment, impose a fine exceeding two lakh rupees.”

7. It is thus apparent that what is made punishable under Section 21 is possession, sale, purchase, etc. of the drugs and preparations mentioned therein in contravention of any provision of the Act or any rule or order made or condition of licence granted thereunder. Obviously, therefore, if any rule permits a person to possess any psychotropic substance within the limits specified under the rule and subject to such conditions as the rule may prescribe, such a person cannot be held guilty of the offence under Section 21 of the Act if it is shown that his possession is not in contravention of such rule.

8. Rule 66 of the Narcotic Drugs and Psychotropic Substances Rules, 1985 (hereinafter referred to as “the NDPS Rules”) provides as follows:

“66. Possession, etc. of psychotropic substances.—(1) No person shall possess any psychotropic substance for any of the purposes covered by the 1945 Rules, unless he is lawfully authorized to possess such substance for any of the said purposes under these Rules.
(2) Notwithstanding anything contained in sub-rule (1), any research institution, or a hospital or dispensary maintained or supported by Government or local body or by charity or voluntary subscription, which is not authorized to possess any psychotropic substance under the 1945 Rules, or any person who is not so authorized under the 1945 Rules, may possess a reasonable quantity of such substance as may be necessary for their genuine scientific requirements or genuine medical requirements, or both for such period as is deemed necessary by the said research institution or, as the case may be, the said hospital or dispensary or person:
Provided that where such psychotropic substance is in possession of an individual for his personal medical use the quantity thereof shall not exceed one hundred dosage units at a time.
(3) The research institution, hospital and dispensary referred to in sub-rule (2) shall maintain proper accounts and records in relation to the purchase and consumption of the psychotropic substance in their possession.”

9. Sub-rule (2) therefore permits a person to keep in his possession for his personal medicinal use the psychotropic substance up to one hundred dosage units at a time.

10. In the instant case there is evidence on record which indicates that the appellant used the said drug and this is obvious from the deposition of the investigating officer, PW 3 as well as the deposition of his mother, DW 1. Moreover, three syringes were also recovered from the appellant which also is indicative of the fact that the psychotropic substance recovered from him was for his personal consumption and not for trading purposes.

11. In similar circumstances this Court in Ouseph v. State of Kerala Criminal Appeal No. 1256 of 2001 drew such an inference. There also the accused was found to possess 110 ampoules of the same psychotropic substance together with two syringes.

12. In Hussain v. State of Kerala (2000) 8 SCC 139 the appellant was found to possess six ampoules of the same psychotropic substance. This Court allowed the appeal preferred by the accused giving him the benefit of Rule 66 of the NDPS Rules which permitted the appellant to keep in his possession for his personal medicinal use the psychotropic substance up to 100 dosage units at a time.

13. Learned counsel for the State submitted that unless the appellant held a permit granted under Rule 66 of the NDPS Rules, he cannot claim benefit under the provisions of that rule. We find no substance in the argument because having regard to the provisions of Section 9 of the NDPS Act under which the Rules have been framed, the Central Government is empowered by the Rules to permit and regulate the matters mentioned therein. Rule 66 itself permits possession of psychotropic substance below a specified quantity and subject to the conditions stated therein. Thus if the possession of psychotropic substance is justified under the said rule, no separate permit is required to be issued to the person possessing such psychotropic substance because the rule itself permits possession of such psychotropic substance to the extent mentioned in the rule and subject to the conditions laid down therein. Thus following the principle laid down in Hussain v. State of Kerala (2000) 8 SCC 139 and having regard to the provisions of Rule 66 of the NDPS Rules read with Section 21 of the NDPS Act, we are satisfied that the psychotropic substance, namely, buprenorphine hydrochloride (Tidigesic) found in possession of the appellant was not in breach of Rule 66 of the NDPS Rules and having regard to the fact that the same was for his personal consumption, no offence under Section 21 of the NDPS Act is made out.

14. In the result this appeal is allowed and the appellant is acquitted of the charge levelled against him. The appellant is on bail. His bail bonds are discharged.